Attached files
file | filename |
---|---|
10-Q - NUTRA PHARMA CORP | nutra_10q.htm |
EX-31.1 - NUTRA PHARMA CORP | ex31_1.htm |
EXCEL - IDEA: XBRL DOCUMENT - NUTRA PHARMA CORP | Financial_Report.xls |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Nutra Pharma Corp., (the "Company") on Form 10-Q for the quarterly period ended June 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Rik J Deitsch, the Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: August 14, 2014
|
||||
/s/ Rik J. Deitsch
|
||||
Rik J. Deitsch
|
||||
Chief Executive Officer and Chief Financial Officer
|